يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"А. Х. Тальдаев"', وقت الاستعلام: 0.79s تنقيح النتائج
  1. 1
    Academic Journal

    المساهمون: This work was financed by the Russian Science Foundation (No 23-75-01130), https://rscf.ru/project/23-75-01130/, Исследование выполнено за счет гранта Российского научного фонда № 23-75-01130, https://rscf.ru/project/23-75-01130/

    المصدر: Drug development & registration; Том 13, № 2 (2024); 68-76 ; Разработка и регистрация лекарственных средств; Том 13, № 2 (2024); 68-76 ; 2658-5049 ; 2305-2066

    وصف الملف: application/pdf

    Relation: https://www.pharmjournal.ru/jour/article/view/1817/1277; https://www.pharmjournal.ru/jour/article/downloadSuppFile/1817/2262; Liu Y., Shi X., Tian Y., Zai S., Liu Y., Xiong Z., Chu S. An insight into novel therapeutic potentials of taxifolin. Frontiers in Pharmacology. 2023;14:1173855. DOI:10.3389/fphar.2023.1173855.; Vladimirov Yu. A., Proskurnina E. V., Demin E. M., Matveeva N. S., Lubitskiy O. B., Novikov A. A., Izmailov D. Yu., Osipov A. N., Tikhonov V. P., Kagan V. E. Dihydroquercetin (taxifolin) and other flavonoids as inhibitors of free radical formation at key stages of apoptosis. Biochemistry (Moscow). 2009;74(3):301–307. DOI:10.1134/S0006297909030092.; Orlova S. V., Tatarinov V. V., Nikitina E. A., Sheremeta A. V., Ivlev V. A., Vasil’ev V. G., Paliy K. V., Goryainov S. V. Bioavailability and Safety of Dihydroquercetin (Review). Pharmaceutical Chemistry Journal. 2022;55(11):1133–1137.; Kalinina I., Potoroko I., Sonawane S. H. Sonochemical encapsulation of taxifolin into cyclodextrine for improving its bioavailability and bioactivity for food. In: Encapsulation of Active Molecules and Their Delivery System. Amsterdam: Elsevier; 2020. P. 85–102. DOI:10.1016/B978-0-12-819363-1.00005-3.; Abdulrazzak S. A., Vorobyev A. N., Sinitsyna N. I., Sharutin I. V., Menshova O. V., Elizarova E. V., Ivanov Yu. V., Karamyan A. S., Abramovich R. A., Potanina O. G., Sakanyan K. M. Development of Dihydroquercetin-based Oral tablets and Evalution of the General Toxic Effect. Drug development & registration. 2022;11(2):126–138. (In Russ.) DOI:10.33380/2305-2066-2022-11-2-126-138.; Terekhov R. P., Selivanova I. A., Tyukavkina N. A., Ilyasov I. R., Zhevlakova A. K., Dzuban A. V., Bogdanov A. G., Davidovich G. N., Shylov G. V., Utenishev A. N., Kovalev D. Yu., Fenin A. A., Kabluchko T. G. Assembling the Puzzle of Taxifolin Polymorphism. Molecules. 2020;25(22):5437. DOI:10.3390/molecules25225437.; Stenger Moura F. C., Pinna N., Vivani R., Nunes G. E., Schoubben A., Bellé Bresolin T. M., Bechold I. H., Ricci M. Exploring Taxifolin Polymorphs: Insights on Hydrate and Anhydrous Forms. Pharmaceutics. 2021;13(9):1328. DOI:10.3390/pharmaceutics13091328.; Taldaev A., Terekhov R. P., Selivanova I. A., Pankov D. I., Anurova M. N., Markovina I. Yu., Cong Z., Ma S., Dong Z., Yang F., Liao Y. Modification of Taxifolin Properties by Spray Drying. Scientia Pharmaceutica. 2022;90(4):67. DOI:10.3390/scipharm90040067.; Terekhov R. P., Melnikov E. S., Nikitin I. D., Tokareva M. A., Rodina T. A., Savina A. D., Pankov D. I., Zhevlakova A. K., Beloborodov V. L., Selivanova I. A. Diastereomers of Spheroidal Form and Commercially Available Taxifolin Samples. Scientia Pharmaceutica. 2024;92(1):5. DOI:10.3390/scipharm92010005.; Vega-Villa K. R., Remsberg C. M., Takemoto J. K., Ohgami Yu., Yáñez J. A., Andrews P. K., Davies N. M. Stereospecific pharmacokinetics of racemic homoeriodictyol, isosakuranetin, and taxifolin in rats and their disposition in fruit. Chirality. 2011;23(4):339–348. DOI:10.1002/chir.20926.; Strugar Y., Orlova A. A., Ponkratova A. A., Whaley A. K., Povydysh M. N. Isolation of Individual Compounds from the Aerial Part of Comarum palustre L. and Their Structure Elucidation Using Spectroscopic Methods. Drug development & registration. 2022;11(4):177–184. (In Russ.). DOI:10.33380/2305-2066-2022-11-4-177-184.; Achanta P. S., Jaki B. U., McAlpine J. B., Friesen J. B., Niemitz M., Chen S.-N., Pauli G. F. Quantum mechanical NMR full spin analysis in pharmaceutical identity testing and quality control. Journal of Pharmaceutical and Biomedical Analysis. 2021;192:113601. DOI:10.1016/j.jpba.2020.113601.; Achanta P. S., Niemitz M., Friesen J. B., Tadjimukhamedov F. K., Bzhelyansky A., Giancaspro G. I., Chen S.-N., Pauli G. F. Pharmaceutical analysis by NMR can accommodate strict impurity thresholds: The case of choline. Journal of Pharmaceutical and Biomedical Analysis. 2022;214:114709. DOI:10.1016/j.jpba.2022.114709.; Belov K. V., Batista de Carvalho L. A. E., Dyshin A. A., Efimov S. V., Khodov I. A. The Role of Hidden Conformers in Determination of Conformational Preferences of Mefenamic Acid by NOESY Spectroscopy. Pharmaceutics. 2022;14(11):2276. DOI:10.3390/pharmaceutics14112276.; Mironov V. F., Nemtarev A. V., Tsepaeva O. V., Dimukhametov M. N., Litvinov I. A., Voloshina A. D., Pashirova T. N., Titov E. A., Lyubina A. P., Amerhanova S. K., Gubaidullin A. T., Islamov D. R. Rational Design 2-Hydroxypropylphosphonium Salts as Cancer Cell Mitochondria-Targeted Vectors: Synthesis, Structure, and Biological Properties. Molecules. 2021;26(21):6350. DOI:10.3390/molecules26216350.; Bozin T. N., Berdyshev I. M., Chukhontseva K. N., Karaseva M. A., Konarev P. V., Varizhuk A. M., Lesovoy D. M., Arseniev A. S., Kostrov S. V., Bocharov E. V., Demidyuk I. V. NMR structure of emfourin, a novel protein metalloprotease inhibitor: Insights into the mechanism of action. Journal of Biological Chemistry. 2023;299(4):104585. DOI:10.1016/j.jbc.2023.104585.; Urban A. S., Pavlov K. V., Kamynina A. V., Okhrimenko I. S., Arseniev A. S., Bocharov E. V. Structural Studies Providing Insights into Production and Conformational Behavior of Amyloid-β Peptide Associated with Alzheimer’s Disease Development. Molecules. 2021;26(10):2897. DOI:10.3390/molecules26102897.; Panina I. S., Balandin S. V., Tsarev A. V., Chugunov A. O., Tagaev A. A., Finkina E. I., Antoshina D. V., Sheremeteva E. V., Paramonov A. S., Rickmeyer J., Bierbaum G., Efremov R. G., Shenkarev Z. O., Ovchinnikova T. V. Specific Binding of the α-Component of the Lantibiotic Lichenicidin to the Peptidoglycan Precursor Lipid II Predetermines Its Antimicrobial Activity. International Journal of Molecular Sciences. 2023;24(2):1332. DOI:10.3390/ijms24021332.; Skinner S. P., Fogh R. H., Boucher W., Ragan T. J., Mureddu L. G., Vuister G. W. CcpNmr Analysis Assign: a flexible platform for integrated NMR analysis. Journal of Biomolecular NMR. 2016;66(2):111–124. DOI:10.1007/s10858-016-0060-y.; Terekhov R. P., Selivanova I. A., Tyukavkina N. A., Shylov G. V., Utenishev A. N., Porozov Yu. B. Taxifolin tubes: crystal engineering and characteristics. Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials. 2019;75(2):175–182. DOI:10.1107/S2052520619000969.; Nifant’ev E. E., Koroteev M. P., Kaziev G. Z., Uminskii A. A., Grachev A. A., Men’shov V. M., Tsvetkov Yu. E., Nifant’ev N. E., Bel’skii V. K., Stash A. I. On the problem of identification of the dihydroquercetin flavonoid. Russian Journal of General Chemistry. 2006;76:161–163. DOI:10.1134/S1070363206010324.; Selivanova I. A., Tyukavkina N. A., Kolesnik Yu. A., Nesterov V. N., Kuleshova L. N., Khutoryanskii V. A., Bazhenov B. N., Saibotalov M. Yu. Study of the crystalline structure of dihydroquercetin. Pharmaceutical Chemistry Journal. 1999;33:222–224. DOI:10.1007/BF02509946.; Khlupova M., Vasil’eva I., Shumakovich G., Zaitseva E., Chertkov V., Shestakova A., Morozova O., Yaropolov A. Enzymatic Polymerization of Dihydroquercetin (Taxifolin) in Betaine-Based Deep Eutectic Solvent and Product Characterization. Catalysts. 2021;11(5):639. DOI:10.3390/catal11050639.; Varlamova E. G., Uspalenko N. I., Khmil N. V., Shigaeva M. I., Stepanov M. R., Ananyan M. A., Timchenko M. A., Molchanov M. V, Mironova G. D., Turovsky E. A. A Comparative Analysis of Neuroprotective Properties of Taxifolin and Its Water-Soluble Form in Ischemia of Cerebral Cortical Cells of the Mouse. International Journal of Molecular Sciences. 2023;24(14):11436. DOI:10.3390/ijms241411436.; Rabbi F., Zada A., Nisar A., Sohail M., Khalil S. K., Shah W. A. Bioassay-Guided Isolation, Identification of Compounds from Sterculia diversifolia and Investigation of Their Anti-Glycation and Antioxidant Activities. Pharmaceutical Chemistry Journal. 2020;53:1137–1144. DOI:10.1007/s11094-020-02137-7.; Lundgren L. N., Theander O. Cis- and trans-dihydroquercetin glucosides from needles of Pinus sylvestris. Phytochemistry. 1988;27(3):829–832. DOI:10.1016/0031-9422(88)84101-3.; Kiehlmann E., Li E. P. M. Isomerization of Dihydroquercetin. Journal of Natural Products. 1995;58(3):450–455. DOI:10.1021/np50117a018.; Ohmura W., Ohara S., Hashida K., Aoyama M., Dоi S. Hydrothermolysis of Flavonoids in Relation to Steaming of Japanese Larch Wood. Holzforschung. 2002;56(5):493–497. DOI:10.1515/HF.2002.076.; Turnbull J. J., Nakajima J.-I., Welford R. W. D., Yamazaki M., Saito K., Schofield C. J. Mechanistic studies on three 2-oxoglutarate-dependent oxygenases of flavonoid biosynthesis. Journal of Biological Chemistry. 2004;279(2):1206–1216. DOI:10.1074/JBC.M309228200.; Yoon K. D., Lee J.-Y., Kim T. Y., Kang H., Ha K.-S., Ham T.-H., Ryu S. N., Kang M.-Y., Kim Y.-H., Kwon Y.-I. In Vitro and in Vivo Anti-Hyperglycemic Activities of Taxifolin and Its Derivatives Isolated from Pigmented Rice (Oryzae sativa L. cv. Superhongmi). Journal of Agricultural and Food Chemistry. 2020;68(3):742–750. DOI:10.1021/acs.jafc.9b04962.; Kuspradini H., Mitsunaga T., Ohashi H. Antimicrobial activity against Streptococcus sobrinus and glucosyltransferase inhibitory activity of taxifolin and some flavanonol rhamnosides from kempas (Koompassia malaccensis) extracts. Journal of Wood Science. 2009;55:308–313. DOI:10.1007/s10086-009-1026-4.; Baderschneider B., Winterhalter P. Isolation and Characterization of Novel Benzoates, Cinnamates, Flavonoids, and Lignans from Riesling Wine and Screening for Antioxidant Activity. Journal of Agricultural and Food Chemistry. 2001;49(6):2788–2798. DOI:10.1021/jf010396d.; Podgorskii V. V., Mikhalev A. S., Kalabin G. A. Quantitative NMR spectroscopy for quality control of drugs and pharmaceuticals. Pharmaceutical Chemistry Journal. 2011;45:194–197. DOI:10.1007/s11094-011-0591-1.; Kuz’mina N. E., Moiseev S. V., Khorolskiy M. D., Lutceva A. I. Development and Validation of 2-Azaspiro [4,5] Decan-3-One (Impurity A) in Gabapentin Determination Method Using qNMR Spectroscopy. Molecules. 2021;26(6):1656. DOI:10.3390/molecules26061656.; El-Adl S. M., El-sadek M. E., Hasan M. H. Determination and Validation of Piracetam in Pharmaceuticals Using Quantitative Nuclear Magnetic Resonance Spectroscopy. Analytical Chemistry Letters. 2017;7(2):271–279. DOI:10.1080/22297928.2017.1320227.; Schleiff M., Sommers C., Yang J., Shen X., Rodriguez J. D., Shu Q. Development and validation of a quantitative proton NMR method for the analysis of pregnenolone. SSRN Electronic Journal. 2023;222:115073. DOI:10.2139/ssrn.4151644.; Sheng J., Danowski W., Crespi S., Guinart A., Chen X., Stähler C., Feringa B. L. Designing P-type bi-stable overcrowded alkene-based chiroptical photoswitches. Chemical Science. 2023;14(16):4328–4336. DOI:10.1039/d2sc05903g.; Aiken S., De Azevedo O. D. C. C., Chauhan K., Gabbutt C. D., Heron B. M., Rice C. R., Soltowska N. Synthesis of photochromic 3-arylvinyl-3H-naphtho[2,1-b]pyrans: An unexpected one-step annulation to cyclopenta[b]naphtho[1,2-d]furans. Dyes and Pigments. 2022;207:110710. DOI:10.1016/j.dyepig.2022.110710.; Danowski W., van Leeuwen T., Browne W. R., Feringa B. L. Photoresponsive porous materials. Nanoscale Advances. 2021;3(1):24–40. DOI:10.1039/D0NA00647E.; Nesterova M., Cobra P. F., Markley J. L. Taxifolin. Biological Magnetic Resonance Bank. 2019. DOI:10.13018/BMSE001302.; Taldaev A. Kh., Nikitin I. D., Terekhov R. P., Selivanova I. A. Molecular Docking: Methodological Approaches of Risk Assessment. Drug development & registration. 2023;12(2):206–210. (In Russ.) DOI:10.33380/2305-2066-2023-12-2-206-210.; https://www.pharmjournal.ru/jour/article/view/1817

  2. 2
    Academic Journal

    المساهمون: This work was financed by the Ministry of Science and Higher Education of the Russian Federation within the framework of state support for the creation and development of World-Class Research Centers "Digital Biodesign and Personalized Healthcare" (No 075-15-2022-305)., Работа выполнена в рамках проекта по созданию и развитию научных центров мирового уровня «Цифровой биодизайн и персонализированное здравоохранение» при финансовой поддержке Министерства образования и науки Российской Федерации (соглашение № 075-15-2022-305).

    المصدر: Drug development & registration; Том 12, № 2 (2023); 206-210 ; Разработка и регистрация лекарственных средств; Том 12, № 2 (2023); 206-210 ; 2658-5049 ; 2305-2066

    وصف الملف: application/pdf

    Relation: https://www.pharmjournal.ru/jour/article/view/1501/1134; https://www.pharmjournal.ru/jour/article/downloadSuppFile/1501/1649; Terekhov R. P., Nikitin I. D., Taldaev A. Kh., Selivanova I. A. Computer modeling of the interaction between flavonoids and biological targets. Pharmaceutical Business and Drug Technology. 2021;2:24–36. (In Russ.) DOI:10.33920/med-13-2102-01.; Kumar A., Zhang K. Y. J. Hierarchical virtual screening approaches in small molecule drug discovery. Methods. 2015;71(1):26–37. DOI:10.1016/j.ymeth.2014.07.007.; Onufriev A. V., Alexov E. Protonation and pK changes in protein–ligand binding. Quarterly Reviews of Biophysics. 2013;46(2):181–209. DOI:10.1017/S0033583513000024.; Vieth M., Hirst J. D., Brooks C. L. Do active site conformations of small ligands correspond to low free-energy solution structures? Journal of Computer-Aided Molecular Design. 1998;12:563–572. DOI:10.1023/A:1008055202136.; Höltje H.-D., Sippl W., Rognan D., Folkers G. Molecular Modeling: Basic Principles and Applications. 3rd Edition. New Jersey: Wiley-VCH; 2008. 320 p.; Billeter M. Comparison of protein structures determined by NMR in solution and by X-ray diffraction in single crystals. Quarterly Reviews of Biophysics. 1992;25(3):325–377. DOI:10.1017/S0033583500004261.; Lohning A. E., Levonis S. M., Williams-Noonan B., Schweiker S. S. A Practical Guide to Molecular Docking and Homology Modelling for Medicinal Chemists. Current Topics in Medicinal Chemistry. 2017;17(18):2023–2040. DOI:10.2174/1568026617666170130110827.; Riccardi L., Genna V., de Vivo M. Metal–ligand interactions in drug design. Nature Reviews Chemistry. 2018;2:100-112. DOI:10.1038/s41570-018-0018-6.; Kim M. O., Nichols S. E., Wang Y., McCammon J. A. Effects of histidine protonation and rotameric states on virtual screening of M. tuberculosis RmlC. Journal of Computer-Aided Molecular Design. 2013;27(3):235–246. DOI:10.1007/s10822-013-9643-9.; Chen Y.-C. Beware of docking! Trends in Pharmacological Sciences. 2015;36(2):78–95. DOI:10.1016/j.tips.2014.12.001.; Bender B. J., Gahbauer S., Luttens A., Lyu J., Webb C. M., Stein R. M., Fink E. A., Balius E. A., Balius T. E., Carlsson J., Irwin J. J., Shoichet B. K. A practical guide to large-scale docking. Nature Protocols. 2021;16:4799–4832. DOI:10.1038/s41596-021-00597-z.; Macip G., Garcia-Segura P., Mastres-Truyol J., Saldivar-Espinoza B., Ojeda-Montes M. J., Gimeno A., Cereto-Massagué A., Garcia-Vallvé S., Pujadas G. Haste makes waste: A critical review of docking-based virtual screening in drug repurposing for SARS-CoV-2 main protease (M-pro) inhibition. Medicinal Research Reviews. 2022;42(2):744–769. DOI:10.1002/med.21862.; https://www.pharmjournal.ru/jour/article/view/1501